Cargando…

Role of MicroRNA in Endothelial Dysfunction and Hypertension

PURPOSE OF REVIEW: Hypertension is either a cause or a consequence of the endothelial dysfunction and a major risk factor for cardiovascular disease (CVD). In vitro and in vivo studies established that microRNAs (miRNAs) are decisive for endothelial cell gene expression and function in various patho...

Descripción completa

Detalles Bibliográficos
Autores principales: Nemecz, Miruna, Alexandru, Nicoleta, Tanko, Gabriela, Georgescu, Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102349/
https://www.ncbi.nlm.nih.gov/pubmed/27837398
http://dx.doi.org/10.1007/s11906-016-0696-8
_version_ 1783511805470965760
author Nemecz, Miruna
Alexandru, Nicoleta
Tanko, Gabriela
Georgescu, Adriana
author_facet Nemecz, Miruna
Alexandru, Nicoleta
Tanko, Gabriela
Georgescu, Adriana
author_sort Nemecz, Miruna
collection PubMed
description PURPOSE OF REVIEW: Hypertension is either a cause or a consequence of the endothelial dysfunction and a major risk factor for cardiovascular disease (CVD). In vitro and in vivo studies established that microRNAs (miRNAs) are decisive for endothelial cell gene expression and function in various pathological conditions associated with CVD. This review provides an overview of the miRNA role in controlling the key connections between endothelial dysfunction and hypertension. RECENT FINDINGS: Herein we summarize the present understanding of mechanisms underlying hypertension and its associated endothelial dysfunction as well as the miRNA role in endothelial cells with accent on the modulation of renin-angiotensin-aldosterone-system, nitric oxide, oxidative stress and on the control of vascular inflammation and angiogenesis in relation to endothelial dysfunction in hypertension. In particular, latest insights in the identification of endothelial-specific microRNAs and their targets are added to the understanding of miRNA significance in hypertension. SUMMARY: This comprehensive knowledge of the role of miRNAs in endothelial dysfunction and hypertension and of molecular mechanisms proposed for miRNA actions may offer novel diagnostic biomarkers and therapeutic targets for controlling hypertension-associated endothelial dysfunction and other cardiovascular complications.
format Online
Article
Text
id pubmed-7102349
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-71023492020-03-31 Role of MicroRNA in Endothelial Dysfunction and Hypertension Nemecz, Miruna Alexandru, Nicoleta Tanko, Gabriela Georgescu, Adriana Curr Hypertens Rep Hypertension and Metabolic Syndrome (J Sperati, Section Editor) PURPOSE OF REVIEW: Hypertension is either a cause or a consequence of the endothelial dysfunction and a major risk factor for cardiovascular disease (CVD). In vitro and in vivo studies established that microRNAs (miRNAs) are decisive for endothelial cell gene expression and function in various pathological conditions associated with CVD. This review provides an overview of the miRNA role in controlling the key connections between endothelial dysfunction and hypertension. RECENT FINDINGS: Herein we summarize the present understanding of mechanisms underlying hypertension and its associated endothelial dysfunction as well as the miRNA role in endothelial cells with accent on the modulation of renin-angiotensin-aldosterone-system, nitric oxide, oxidative stress and on the control of vascular inflammation and angiogenesis in relation to endothelial dysfunction in hypertension. In particular, latest insights in the identification of endothelial-specific microRNAs and their targets are added to the understanding of miRNA significance in hypertension. SUMMARY: This comprehensive knowledge of the role of miRNAs in endothelial dysfunction and hypertension and of molecular mechanisms proposed for miRNA actions may offer novel diagnostic biomarkers and therapeutic targets for controlling hypertension-associated endothelial dysfunction and other cardiovascular complications. Springer US 2016-11-11 2016 /pmc/articles/PMC7102349/ /pubmed/27837398 http://dx.doi.org/10.1007/s11906-016-0696-8 Text en © Springer Science+Business Media New York 2016 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Hypertension and Metabolic Syndrome (J Sperati, Section Editor)
Nemecz, Miruna
Alexandru, Nicoleta
Tanko, Gabriela
Georgescu, Adriana
Role of MicroRNA in Endothelial Dysfunction and Hypertension
title Role of MicroRNA in Endothelial Dysfunction and Hypertension
title_full Role of MicroRNA in Endothelial Dysfunction and Hypertension
title_fullStr Role of MicroRNA in Endothelial Dysfunction and Hypertension
title_full_unstemmed Role of MicroRNA in Endothelial Dysfunction and Hypertension
title_short Role of MicroRNA in Endothelial Dysfunction and Hypertension
title_sort role of microrna in endothelial dysfunction and hypertension
topic Hypertension and Metabolic Syndrome (J Sperati, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102349/
https://www.ncbi.nlm.nih.gov/pubmed/27837398
http://dx.doi.org/10.1007/s11906-016-0696-8
work_keys_str_mv AT nemeczmiruna roleofmicrornainendothelialdysfunctionandhypertension
AT alexandrunicoleta roleofmicrornainendothelialdysfunctionandhypertension
AT tankogabriela roleofmicrornainendothelialdysfunctionandhypertension
AT georgescuadriana roleofmicrornainendothelialdysfunctionandhypertension